Status:
COMPLETED
Trop-Shock DFT-testing Versus None
Lead Sponsor:
Deutsches Herzzentrum Muenchen
Conditions:
Defibrillation Testing - ICD Therapy Optimisation
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
Implantation of a cardioverter defibrillator (ICD) is the treatment of choice for primary and secondary prevention of sudden cardiac death. Traditionally, intraoperative testing for sensing and defibr...
Eligibility Criteria
Inclusion
- ICD-Implantation in patients with coronary artery disease or dilative cardiomyopathy
Exclusion
- Atrial fibrillation with inappropriate anticoagulation
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
195 Patients enrolled
Trial Details
Trial ID
NCT01230086
Start Date
August 1 2010
End Date
June 1 2013
Last Update
April 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Technische Universität München
München, Bavaria, Germany, 80636